Bio-Rad Laboratories, Inc. (CA, USA) recently launched its ddPCR Microsatellite Instability (MSI) Assay, which detects instability in the genome that makes people susceptible to colorectal cancer and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Standardization is needed in CAR-T cell therapy development due to its inherent complexity. Chimeric antigen receptor (CAR)-T cells have already changed how certain cancers are treated. As of February ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced the launch of the QX700 System-compatible Vericheck ddPCR Kit portfolio for ...

Study findings indicate that droplet digital polymerase chain reaction (ddPCR) may be more accurate than real-time quantitative PCR in measuring minimal residual disease (MRD) among pediatric patients ...

Using more exacting analytical tools can give a clearer assessment of gene-editing outcomes. Although many have never heard of it, β-thalassemia is one of the most common autosomal recessive diseases ...

A recent review took a look at the promise of measuring circulating tumor DNA (ctDNA) with digital-droplet PCR (ddPCR) in pancreatic ductal adenocarcinoma (PDAC) as the landscape of this cancer ...

Bio-Rad (CA, USA), a clinical diagnostics products company, has launched a new ddPCR kit designed to assess AAV vector quality for gene therapy development. Vericheck ddPCR Empty-Full Capsid Kit can ...

Cell-based therapies and other advanced biologics have transformed the pharmaceutical landscape, but they’ve also introduced new challenges for quality control (QC). One persistent threat to the ...

Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb) today released the One-Step RT-ddPCR Advanced Kit for Probes which combines reverse transcription and Droplet Digital PCR (RT-ddPCR) for absolute RNA ...